Please provide your email address to receive an email when new articles are posted on . Fewer patients with COPD experienced altitude-related adverse health effects at 3,100 m with acetazolamide vs.
Acetazolamide may prevent some patients with chronic obstructive pulmonary disease (COPD) from suffering altitude-related adverse health effects (ARAHE) when traveling, a randomized controlled trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results